Clinical Trials | December 13, 2023
Progenesis opens genetic laboratory in New Delhi and AI & Bioinformatics data centre in Chennai
Leading USA based genetic testing brand officially enters the Indian market
Leading USA based genetic testing brand officially enters the Indian market
Demonstrate significant bleed reduction in hemophilia A and B
This acquisition marks Max Healthcare's entry into Lucknow
Express Scripts to add Zepbound to National Preferred Formulary
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Multi-ethnic innovation helps all complexions appear clearer and more uniform
Subscribe To Our Newsletter & Stay Updated
